Stay updated on Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T10:36:20.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:25:34.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The notice about a lapse in government funding and related operating-status updates has been removed from the page.
    Difference
    0.3%
    Check dated 2025-11-17T19:16:32.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The update appears to show only minor layout adjustments with no changes to the core study content, such as design, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:44:06.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Core content updated with new government-status notice and version 3.2.0; a specific resource entry (Small cell lung carcinoma) was deleted (v3.1.0).
    Difference
    4%
    Check dated 2025-10-06T04:13:58.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    - Updated the page version from v3.0.2 to v3.1.0. Minor overall impact, mainly reflects a version increment.
    Difference
    0.1%
    Check dated 2025-09-28T23:35:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.